Dissemin is shutting down on January 1st, 2025

Published in

Bentham Science Publishers, Current Pharmaceutical Design, 9(19), p. 1699-1709

DOI: 10.2174/1381612811319090017

Bentham Science Publishers, Current Pharmaceutical Design, 9(19), p. 1699-1709

DOI: 10.2174/138161213805219739

Links

Tools

Export citation

Search in Google Scholar

Impact of Cellular Senescence in Aging and Cancer

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Cellular senescence is a response to nonlethal intrinsic or extrinsic stress that results in persistent growth arrest with a distinct morphological and bio¬chemical phenotype. The engagement of senescence may represent a key component for therapeutic intervention in the eradication of cancer. Nevertheless, for many years, the role of senescence in opposing tumour growth in vivo had previously been underestimated. The potential role of cellular senescence in anti-cancer therapy may be particularly attractive in advanced age, because of the age-related changes occurring at the level of both tumor suppressor genes and immune functions. This review, which is focused on the impact of cellular senescence in aging and cancer, summarises the intrinsic pathways and the molecular and epigenetic changes involved in the induction of cellular senescence, and analyzes the changes occurring at the level of these pathways during aging and cancer.